Two Day Conference on Cell Therapy Bioprocessing (Boston, MA, United States - June 25-26, 2020) - Gain Insight into the Latest Advancements and Opportunities in the Cell-Gene Therapy Manufacturing Area

News provided by

Feb 04, 2020, 11:00 ET

DUBLIN, Feb. 4, 2020 /PRNewswire/ -- The "2nd Annual Cell Therapy Bioprocessing Conference" conference has been added to ResearchAndMarkets.com's offering.

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are factors like manufacturing maze, investment, logistics and regulatory challenges which prevents cell and gene therapies being widely used.

A unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges is presented at the 2nd Annual Cell Therapy Bioprocessing Conference, taking place at Boston-USA on 25th & 26th June 2020.

Key Highlights

Bioprocessing of 3D cell culture
CHO cell lines bioprocessing
Automation of cellular therapies
AAV vector production
Process development and monitoring of cell-gene therapies
Optimization of cell-gene therapies
Supply chain and reimbursement issues
Regulatory guidelines cell and gene-based medicines

Why Attend

Learn the latest advancement and opportunities in the area of manufacturing of cell-gene therapies
Gain insights in the area of the automated and most effective manufacturing processes
Network with the key professionals addressing the strategies of supply chain and regulatory hurdles

Who Should Attend:

From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies:

Engineers/ Scientists/ Researchers/ Project leaders in:

Bioprocess development
Process development
GMP/Manufacturing
Cellular Therapy
Gene Therapy
Quality Control
Cell Engineering
Regulatory affairs

Agenda:

Day 1: Thursday June 25th

CELL CULTURE TO CELL THERAPY

Self-regulated bioprocessing through bioreactor system for monitored 3D cell culture
Multi-omics study on CHO cell lines engineering and bioprocessing
Solution provider presentation
Morning refreshment and One on One Networking

CELL THERAPY BIOPROCESSING AND DEVELOPMENT

Next generation engineered T cells for cell therapy
Automation of cellular therapies: challenges and solutions
Solution provider presentation
Lunch and One on One Networking
Development of Stem Cell Derived Exosomes for Clinical Applications
Bioprocessing of recombinant adenoassociated virus production by fluorescence spectroscopy
Afternoon refreshment and One on One Networking

PROCESS MONITORING & QUALITY CONTROL

Process development of antigen-specific T cells
Establishing iPSC cell banks derived using reagents and workflows optimized for cell therapy manufacturing
Glycolysis restriction through fermentation technology to preserve T-cell functions and checkpoint therapy
Closing remarks by Chairperson
Drinks reception
End of Conference

Day 2: Friday June 26th

Scale up of allogeneic cell therapy manufacturing in single-use bioreactors: Challenges, insights and solutions
Cell therapy: progress in manufacturing and assessments of potency
Solution provider presentation
Morning refreshment and One on One Networking
Panel Discussion: Autologous vs Allogenic
Quality control and effective purification methods for cell therapy product lines
Solution provider presentation
Lunch and One on One Networking

LOGISTICS, REGULATORY & INVESTMENT

Building a leading edge supply chain, while maintaining flexibility
Raw and starting material control for cell-based medicines
FDA guidelines for regulatory issues involved cell therapy manufacturing
Closing remarks by Chairperson
End of Conference

Speakers:

Shailendra Singh (Shelly), Chief Operating Officer, MarketsandMarkets
Tiffany Rau , Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals, Vanderbilt University
Devyn Smith, Chief Operating Officer, Sigilon Therapeutics
Jan Joseph Melenhorst, Adjunct Associate Professor, Upenn
Ian McNiece, Vice President, Aegle Therapeutics
Patrick J. Hanley , Director of GMP for Immunotherapy, The Children's Research Institute
Scott Burger, Principal, Advanced Cell & Gene Therapy LLC

For more information about this conference visit https://www.researchandmarkets.com/r/z4ezsr

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets